Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 3;22(2):605-614.
doi: 10.1021/acs.jproteome.2c00619. Epub 2023 Jan 27.

CHalf: Folding Stability Made Simple

Affiliations

CHalf: Folding Stability Made Simple

Chad D Hyer et al. J Proteome Res. .

Abstract

The structure of a protein defines its function and integrity and correlates with the protein folding stability (PFS). Quantifying PFS allows researchers to assess differential stability of proteins in different disease or ligand binding states, providing insight into protein efficacy and potentially serving as a metric of protein quality. There are a number of mass spectrometry (MS)-based methods to assess PFS, such as Thermal Protein Profiling (TPP), Stability of Proteins from Rates of Oxidation (SPROX), and Iodination Protein Stability Assay (IPSA). Despite the critical value that PFS studies add to the understanding of mechanisms of disease and treatment development, proteomics research is still primarily dominated by concentration-based studies. We found that a major reason for the lack of PFS studies is the lack of a user-friendly data processing tool. Here we present the first user-friendly software, CHalf, with a graphical user interface for calculating PFS. Besides calculating site-specific PFS of a given protein from chemical denature folding stability assays, CHalf is also compatible with thermal denature folding stability assays. CHalf also includes a set of data visualization tools to help identify changes in PFS across protein sequences and in between different treatment conditions. We expect the introduction of CHalf to lower the barrier of entry for researchers to investigate PFS, promoting the usage of PFS in studies. In the long run, we expect this increase in PFS research to accelerate our understanding of the pathogenesis and pathophysiology of disease.

Keywords: IPSA; SPROX; TPP; graphical user interface; protein folding stability.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
The workflow of CHalf. This figure maps the workflow of CHalf, shows the image of the GUI for each tool, and shows example visualization outputs. Each panel is a module in the program and leads to the next module. The blue text represents the input files required for the next module; the * represents the product output file from the referenced module; and the + represents the function that is excluded for thermal denature experiments. The full size of screenshot of the interface and output are included in Supporting Figure 2 for the details.
Figure 2
Figure 2
Experiment flow of protein folding stability (PFS) assay. (A) Chemical denature based PFS assay denature protein using denaturant like GdmCl or urea and then covalently modify the surface exposed amino acid residues. The labeled peptides serve as the probe for protein stability measurement. (B) Thermal denature based PFS assays denature protein using an increasing temperature gradient. The protein aggregates as the temperature increases. The soluble protein fraction serves as the probe for protein stability measurement.
Figure 3
Figure 3
CHalf graphic result from sample data set. (A–C) The graphic results of IPSA experiment. (D–F) The graphics results of SPROX experiment. For the IPSA and SPROX experiments, a combined site figure for a given label site of a protein is shown on the left column, and the combined residue mapper (the middle column) shows the site C1/2 across a protein’s sequence. (G–I) The graphic results of a TPP experiment. Since the TPP experiment does not label specific site of a protein, the denature curves are used to show the treatment effect on the same peptide. The scatter plot of site C1/2 or peptide Tm (the right column) is used to show the global PFS change due to ligand binding or drug treatment.

References

    1. Outeiro T. F.; Tetzlaff J. Mechanisms of Disease II: Cellular Protein Quality Control. Seminars in Pediatric Neurology 2007, 14 (1), 15–25. 10.1016/j.spen.2006.11.005. - DOI - PubMed
    1. Kaur U.; Meng H.; Lui F.; Ma R.; Ogburn R. N.; Johnson J. H. R.; Fitzgerald M. C.; Jones L. M. Proteome-Wide Structural Biology: An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale. J. Proteome Res. 2018, 17 (11), 3614–3627. 10.1021/acs.jproteome.8b00341. - DOI - PMC - PubMed
    1. Drucker E.; Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA Journal 2013, 4 (1), 7.10.1186/1878-5085-4-7. - DOI - PMC - PubMed
    1. Franken H.; Mathieson T.; Childs D.; Sweetman G. M. A.; Werner T.; Tögel I.; Doce C.; Gade S.; Bantscheff M.; Drewes G.; et al. Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry. Nat. Protoc. 2015, 10 (10), 1567–1593. 10.1038/nprot.2015.101. - DOI - PubMed
    1. Walker E. J.; Bettinger J. Q.; Welle K. A.; Hryhorenko J. R.; Ghaemmaghami S. Global analysis of methionine oxidation provides a census of folding stabilities for the human proteome. Proc. Natl. Acad. Sci. U. S. A. 2019, 116 (13), 6081–6090. 10.1073/pnas.1819851116. - DOI - PMC - PubMed

Publication types